<?php

namespace Database\Seeders;

use App\Models\Meeting\Hall\Program\Session\Session;
use Illuminate\Database\Seeder;

class MeetingHallProgramSessionSeeder extends Seeder
{
    public function run(): void
    {
        Session::insert([
           [
                'sort_order' => '10',
                'program_id' => 8,
                'speaker_id' => 18,
                'code' => 'panel-1-1',
                'title' => 'Kolorektal Kanserinde Neoadjuvan Tedavi',
                'start_at' => '2023-11-02 09:15',
                'finish_at' => '2023-11-02 09:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 1,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 8,
                'speaker_id' => 19,
                'code' => 'panel-1-2',
                'title' => 'Kolon Kanserinde Adjuvan Tedavi: Kime ve Nasıl?',
                'start_at' => '2023-11-02 09:35',
                'finish_at' => '2023-11-02 09:55',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 8,
                'speaker_id' => 20,
                'code' => 'panel-1-3',
                'title' => 'Metastatik Kolon Kanserinde Yeni Hedefe Yönelik Tedavi Seçenekleri',
                'start_at' => '2023-11-02 09:55',
                'finish_at' => '2023-11-02 10:15',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '40',
                'program_id' => 8,
                'speaker_id' => null,
                'code' => 'panel-1-4',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-02 10:15',
                'finish_at' => '2023-11-02 10:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 9,
                'speaker_id' => 21,
                'code' => null,
                'title' => 'LYNPARZA ile Over ve Meme Kanserlerinde Fark Yaratmaya Var Mısınız?',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 10:45',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 9,
                'speaker_id' => 22,
                'code' => null,
                'title' => 'LYNPARZA ile Over ve Meme Kanserlerinde Fark Yaratmaya Var Mısınız?',
                'start_at' => '2023-11-02 10:45',
                'finish_at' => '2023-11-02 11:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 11,
                'speaker_id' => 23,
                'code' => 'panel-2-1',
                'title' => 'İleri Evre Pankreas Kanserinde Tedaviler',
                'start_at' => '2023-11-02 11:20',
                'finish_at' => '2023-11-02 11:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 11,
                'speaker_id' => 24,
                'code' => 'panel-2-2',
                'title' => 'Mide ve Özofagus Kanserlerinde İmmünoterapi',
                'start_at' => '2023-11-02 11:40',
                'finish_at' => '2023-11-02 12:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 11,
                'speaker_id' => 18,
                'code' => null,
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-02 12:00',
                'finish_at' => '2023-11-02 12:15',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 13,
                'speaker_id' => 25,
                'code' => null,
                'title' => '1.Basamak mKHDAK Tedavisinde Klinik Verilerle CM 9LA ve Opdivo+Yervoy+2 Kür KT Deneyimi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 14:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 14,
                'speaker_id' => 26,
                'code' => 'panel-3-1',
                'title' => 'Endikasyon Dışı İlaç Kullanımında Klinisyen Bakış Açısı',
                'start_at' => '2023-11-02 14:00',
                'finish_at' => '2023-11-02 14:20',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 14,
                'speaker_id' => 27,
                'code' => 'panel-3-2',
                'title' => 'Endikasyon Dışı İlaç Kullanımında Hukuki Süreç',
                'start_at' => '2023-11-02 14:20',
                'finish_at' => '2023-11-02 14:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 14,
                'speaker_id' => null,
                'code' => 'panel-3-3',
                'title' => 'İnteraktif Tartışma',
                'start_at' => '2023-11-02 14:40',
                'finish_at' => '2023-11-02 15:10',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 15,
                'speaker_id' => 28,
                'code' => null,
                'title' => 'Erken Evre Akciğer Kanserinde Cerrahi Yaklaşım',
                'start_at' => '2023-11-02 15:10',
                'finish_at' => '2023-11-02 15:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 15,
                'speaker_id' => 29,
                'code' => null,
                'title' => 'Erken Evre Akciğer Kanserinde  İmmunoterapi',
                'start_at' => '2023-11-02 15:10',
                'finish_at' => '2023-11-02 15:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 18,
                'speaker_id' => 30,
                'code' => 'panel-4-1',
                'title' => 'KHDAK: Patolog Bakış Açısı',
                'start_at' => '2023-11-03 09:15',
                'finish_at' => '2023-11-03 09:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 18,
                'speaker_id' => 31,
                'code' => 'panel-4-2',
                'title' => 'Hedefli Mutasyon Olmayan Metastatik KHDAK’de 1. Basamak Tedaviler',
                'start_at' => '2023-11-03 09:35',
                'finish_at' => '2023-11-03 09:55',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 18,
                'speaker_id' => 32,
                'code' => 'panel-4-3',
                'title' => 'EGFR ve ALK Dışı Mutasyon Pozitif Hastalarda Tedavi',
                'start_at' => '2023-11-03 09:55',
                'finish_at' => '2023-11-03 10:15',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 18,
                'speaker_id' => null,
                'code' => 'panel-4-4',
                'title' => 'EGFR ve ALK Dışı Mutasyon Pozitif Hastalarda Tedavi',
                'start_at' => '2023-11-03 10:15',
                'finish_at' => '2023-11-03 10:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 19,
                'speaker_id' => 33,
                'code' => null,
                'title' => '1L NSCLC KN-189, 407 Çalışmalarının 5 Yıl Sonuçları',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 11:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 19,
                'speaker_id' => 34,
                'code' => null,
                'title' => '1L NSCLC KN-189, 407 Çalışmalarının 5 Yıl Sonuçları',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 11:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 21,
                'speaker_id' => 33,
                'code' => 'panel-5-1',
                'title' => 'Adjuvanda Endokrin Tedavi',
                'start_at' => '2023-11-03 11:15',
                'finish_at' => '2023-11-03 11:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 21,
                'speaker_id' => 34,
                'code' => 'panel-5-2',
                'title' => 'Neoadjuvant Tedavi Sonrası Rezidü Hastalığa Yaklaşım',
                'start_at' => '2023-11-03 11:35',
                'finish_at' => '2023-11-03 11:55',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 21,
                'speaker_id' => null,
                'code' => 'panel-5-3',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-03 11:55',
                'finish_at' => '2023-11-03 12:05',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 22,
                'speaker_id' => 35,
                'code' => null,
                'title' => 'HR(+) HER2(-) Metastatik Meme Kanserinde Yaşam için VALAMOR',
                'start_at' => '2023-11-03 12:05',
                'finish_at' => '2023-11-03 12:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 22,
                'speaker_id' => 36,
                'code' => null,
                'title' => 'HR(+) HER2(-) Metastatik Meme Kanserinde Yaşam için VALAMOR',
                'start_at' => '2023-11-03 12:05',
                'finish_at' => '2023-11-03 12:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 24,
                'speaker_id' => 37,
                'code' => 'panel-6-1',
                'title' => 'Metastatik Triple Negatif Meme Kanserinde Yaklaşım',
                'start_at' => '2023-11-03 13:30',
                'finish_at' => '2023-11-03 13:50',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 24,
                'speaker_id' => 38,
                'code' => 'panel-6-2',
                'title' => 'Metastatik HER2(+) Meme Kanseri Tedavisinde Gelişmeler',
                'start_at' => '2023-11-03 13:50',
                'finish_at' => '2023-11-03 14:10',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 24,
                'speaker_id' => null,
                'code' => 'panel-6-3',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-03 14:10',
                'finish_at' => '2023-11-03 14:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 25,
                'speaker_id' => 39,
                'code' => null,
                'title' => 'Metastatik Üçlü Negatif Meme Kanserinde Standartları Yükseltiyoruz',
                'start_at' => '2023-11-03 14:30',
                'finish_at' => '2023-11-03 15:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 27,
                'speaker_id' => 40,
                'code' => null,
                'title' => 'CROWN ışığında Lorviqua: ALK+ mKHDAK 1. Basamak Tedavisinde Güncel Gelişmeler',
                'start_at' => '2023-11-03 15:15',
                'finish_at' => '2023-11-03 15:45',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 28,
                'speaker_id' => 41,
                'code' => 'panel-7-1',
                'title' => 'Erken Evre Melanomda Tedavi Seçenekleri',
                'start_at' => '2023-11-03 15:45',
                'finish_at' => '2023-11-03 16:05',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 28,
                'speaker_id' => 42,
                'code' => 'panel-7-2',
                'title' => 'Metastatik Melanomda Güncel Tedavi: 1. Basamak ve Ötesi',
                'start_at' => '2023-11-03 16:05',
                'finish_at' => '2023-11-03 16:25',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 28,
                'speaker_id' => null,
                'code' => 'panel-7-3',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-03 16:25',
                'finish_at' => '2023-11-03 16:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 34,
                'speaker_id' => 46,
                'code' => 'panel-8-1',
                'title' => 'Metastatik Böbrek Kanseri Tedavisinde Gelişmeler',
                'start_at' => '2023-11-04 09:15',
                'finish_at' => '2023-11-04 09:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 34,
                'speaker_id' => 47,
                'code' => 'panel-8-2',
                'title' => 'Metastatik Hormon Duyarlı Prostat Kanserinde Tedavi Yaklaşımı',
                'start_at' => '2023-11-04 09:35',
                'finish_at' => '2023-11-04 09:55',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 34,
                'speaker_id' => 48,
                'code' => 'panel-8-3',
                'title' => 'Metastatik Prostat Kanserinde PARP İnhibitörlerinin Yeri',
                'start_at' => '2023-11-04 09:55',
                'finish_at' => '2023-11-04 10:15',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '40',
                'program_id' => 34,
                'speaker_id' => 49,
                'code' => 'panel-8-4',
                'title' => 'Metastatik Mesane Kanseri Tedavisinde Kemoterapinin Ötesi',
                'start_at' => '2023-11-04 10:15',
                'finish_at' => '2023-11-04 10:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '50',
                'program_id' => 34,
                'speaker_id' => null,
                'code' => 'panel-8-5',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-04 10:35',
                'finish_at' => '2023-11-04 11:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 36,
                'speaker_id' => 50,
                'code' => null,
                'title' => 'Prostat Kanseri Tedavisinde Önce XTANDI™',
                'start_at' => '2023-11-04 11:15',
                'finish_at' => '2023-11-04 11:45',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 37,
                'speaker_id' => 51,
                'code' => 'panel-9-1',
                'title' => 'Over Kanserinde HIPEC’ın Yeri Var mı?',
                'start_at' => '2023-11-04 11:45',
                'finish_at' => '2023-11-04 12:05',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 37,
                'speaker_id' => 52,
                'code' => 'panel-9-2',
                'title' => 'Endometrium Kanserinde Kemoterapinin Ötesi',
                'start_at' => '2023-11-04 12:05',
                'finish_at' => '2023-11-04 12:25',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 37,
                'speaker_id' => null,
                'code' => 'panel-9-3',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-04 12:25',
                'finish_at' => '2023-11-04 12:35',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 39,
                'speaker_id' => 53,
                'code' => null,
                'title' => 'Over Kanseri İdame Tedavisinde Zejula ile Yeni Bir Dönem',
                'start_at' => '2023-11-04 13:30',
                'finish_at' => '2023-11-04 14:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 39,
                'speaker_id' => 54,
                'code' => null,
                'title' => 'Over Kanseri İdame Tedavisinde Zejula ile Yeni Bir Dönem',
                'start_at' => '2023-11-04 13:30',
                'finish_at' => '2023-11-04 14:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 39,
                'speaker_id' => 55,
                'code' => null,
                'title' => 'Over Kanseri İdame Tedavisinde Zejula ile Yeni Bir Dönem',
                'start_at' => '2023-11-04 13:30',
                'finish_at' => '2023-11-04 14:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 40,
                'speaker_id' => 56,
                'code' => 'panel-10-1',
                'title' => 'Baş Boyun Kanserinde İmmunoterapi',
                'start_at' => '2023-11-04 14:30',
                'finish_at' => '2023-11-04 14:20',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 40,
                'speaker_id' => 57,
                'code' => 'panel-10-2',
                'title' => 'Sarkomda Kişiselleştirilmiş Tedavi',
                'start_at' => '2023-11-04 14:20',
                'finish_at' => '2023-11-04 14:40',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 40,
                'speaker_id' => 58,
                'code' => 'panel-10-3',
                'title' => 'Kanser Tedavisi Sırasında Beraber Kullandığımız İlaçların Olumsuz Etkileşiminin Farkında mıyız?',
                'start_at' => '2023-11-04 14:40',
                'finish_at' => '2023-11-04 15:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '40',
                'program_id' => 40,
                'speaker_id' => null,
                'code' => 'panel-10-4',
                'title' => 'Soru & Cevap & Tartışma',
                'start_at' => '2023-11-04 15:00',
                'finish_at' => '2023-11-04 15:15',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 42,
                'speaker_id' => 59,
                'code' => null,
                'title' => 'Erken Evre TNBC Tedavisinde Pembrolizumab',
                'start_at' => '2023-11-04 15:30',
                'finish_at' => '2023-11-04 16:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 46,
                'speaker_id' => 60,
                'code' => 'panel-12-1',
                'title' => 'Kanser Ağrısında Opiatlar',
                'start_at' => '2023-11-05 09:30',
                'finish_at' => '2023-11-05 10:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 46,
                'speaker_id' => 61,
                'code' => 'panel-12-2',
                'title' => 'Tirozin Kinaz Grubu İlaçlarda Yan Etki Yönetimi',
                'start_at' => '2023-11-05 10:00',
                'finish_at' => '2023-11-05 10:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 46,
                'speaker_id' => 35,
                'code' => 'panel-12-3',
                'title' => 'Kanserli Hastalarda Beslenme Desteği',
                'start_at' => '2023-11-05 10:30',
                'finish_at' => '2023-11-05 11:00',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 46,
                'speaker_id' => 62,
                'code' => 'panel-12-3',
                'title' => 'Akılcı İlaç Sunumu',
                'start_at' => '2023-11-05 11:00',
                'finish_at' => '2023-11-05 11:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '10',
                'program_id' => 48,
                'speaker_id' => 63,
                'code' => 'S-01',
                'title' => 'Transvers kolon yerleşimli opere nonmetastatik kolon karsinomlu hastalarda hastalıksız sağkalım analizi -Tek merkez deneyimi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '20',
                'program_id' => 48,
                'speaker_id' => 64,
                'code' => 'S-02',
                'title' => 'Erken evre kolon kanseri hastalarında pre-operatif dönemde bakılan kolon inflamatuar indeksinin nükssüz sağkalımla ilişkisi ',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '30',
                'program_id' => 48,
                'speaker_id' => 65,
                'code' => 'S-03',
                'title' => 'Kolon kanserinde PD-1 ekspresyon düzeyi ile evre arasındaki ilişkinin değerlendirilmesi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '40',
                'program_id' => 48,
                'speaker_id' => 66,
                'code' => 'S-04',
                'title' => 'Neoadjuvan tedavi alan rektum kanserli hastalarda beden kitle indeksinin önemi ',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '50',
                'program_id' => 48,
                'speaker_id' => 67,
                'code' => 'S-05',
                'title' => '70 Yaş Üstü Evre-2 Ve Evre-3 Kolon Kanserli Hastalarda Oksaliplatinli Ve Oksaliplatinsiz Adjuvan Kemoterapi Rejimlerinin Karşilaştirilmali Etkinlik Analizi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '60',
                'program_id' => 48,
                'speaker_id' => 68,
                'code' => 'S-06',
                'title' => 'Metastatik kolorektal kanserde hiperüriseminin prognostik önemi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '70',
                'program_id' => 48,
                'speaker_id' => 69,
                'code' => 'S-07',
                'title' => 'Metastatik Kolorektal Kanserde Prognostik Biyobelirteçler: Delta Prognostik Nutrisyon İndeksi, Delta Nötrofil/Lenfosit Oranı Ve Delta Trombosit/Lenfosit Oranı',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '80',
                'program_id' => 48,
                'speaker_id' => 70,
                'code' => 'S-08',
                'title' => 'Metastatik kolorektal kanser hastalarında standart kemoterapi ile bevasizumab kombine tedavinin karaciğer küratif tedavi ve sağkalıma etkisi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '90',
                'program_id' => 48,
                'speaker_id' => 71,
                'code' => 'S-09',
                'title' => 'Tek Merkez Deneyimi; Nöroendokrin Tümörlü Olgularin Serisi',
                'start_at' => '2023-11-02 10:30',
                'finish_at' => '2023-11-02 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '100',
                'program_id' => 49,
                'speaker_id' => 72,
                'code' => 'S-10',
                'title' => 'Küratif rezeksiyon yapılmış mide kanseri vakalarında PD-L1 ekspresyonunun klinikopatolojik parametreler ve sağkalımla ilişkisi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '110',
                'program_id' => 49,
                'speaker_id' => 73,
                'code' => 'S-11',
                'title' => 'Perioperatif Kemoterapi Alan Lokal İleri Mide Kanserli Hastalarda Psoas Kas İndeksinin Klinik Önemi ',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '120',
                'program_id' => 49,
                'speaker_id' => 74,
                'code' => 'S-12',
                'title' => 'Metastatik mide kanseri ile takip edilen hastalarda bilgisayarlı tomografi ile değerlendirilen lomber kas kalınlığının sağ kalım üzerine etkisi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '130',
                'program_id' => 49,
                'speaker_id' => 75,
                'code' => 'S-13',
                'title' => 'Metastatik HER-2 pozitif mide kanseri olgularının retrospektif analizi: tek merkez deneyimi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '140',
                'program_id' => 49,
                'speaker_id' => 76,
                'code' => 'S-14',
                'title' => 'Her-2 Pozitif Mide Kanseri Tedavisine Trastuzumab Eklenmesinin Hastalık Progresyonuna Katkısı; Tek Merkez Deneyimi ',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '150',
                'program_id' => 49,
                'speaker_id' => 77,
                'code' => 'S-15',
                'title' => 'Erken Evre Pankreatikobiliyer Sistem Kanseri Tanılı Hastalarda Genel ve Hastalıksız Sağkalım',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '160',
                'program_id' => 49,
                'speaker_id' => 78,
                'code' => 'S-16',
                'title' => 'İleri evre Hepatosellüler Karsinom tanılı hastalarda sistemik tedavi etkililik ve güvenlilik değerlendirmesi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '170',
                'program_id' => 49,
                'speaker_id' => 79,
                'code' => 'S-17',
                'title' => 'İleri Evre Hepatoselüler Karsinom Tanılı Hastalarda Sağkalımı Etkileyen Faktörler',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '180',
                'program_id' => 49,
                'speaker_id' => 80,
                'code' => 'S-18',
                'title' => 'Kolanjiyokarsinom hastalarında platelet/albümin oranının (PAR) prognostik önemi',
                'start_at' => '2023-11-02 13:30',
                'finish_at' => '2023-11-02 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '190',
                'program_id' => 49,
                'speaker_id' => 81,
                'code' => 'S-19',
                'title' => 'Akciğer kanserinde moleküler testlerin gerçek yaşam verileri: Tek merkez deneyimi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '200',
                'program_id' => 50,
                'speaker_id' => 82,
                'code' => 'S-20',
                'title' => 'Opere olan küçük hücre dışı akciğer kanserli hastalarda primer lezyonunun PET/BT’deki SUV- max değerinin sağkalım için prognostik değeri',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '210',
                'program_id' => 50,
                'speaker_id' => 83,
                'code' => 'S-21',
                'title' => 'Metastatik küçük hücre dışı akciğer kanseri tanılı hastalarda afatinib ve erlotinib tek merkez deneyimi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '220',
                'program_id' => 50,
                'speaker_id' => 84,
                'code' => 'S-22',
                'title' => 'İkinci Basamak Tedavi Olarak Nivolumab Kullanan Küçük Hücreli Dışı Akciğer Kanserli Hastalarda Bazal Metabolizma Hızı ile Sağkalım İlişkisi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '230',
                'program_id' => 50,
                'speaker_id' => 85,
                'code' => 'S-23',
                'title' => 'Metastatik ya da unrezekrabl akciğer kanseri tedavisinde nivolumab tedavi yanıtlılığı ve sistemik inflamatuar index değişimi arasındaki ilişki',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '240',
                'program_id' => 50,
                'speaker_id' => 20,
                'code' => 'S-24',
                'title' => 'Küçük hücreli akciğer kanseri (KHAK) hücre hattında Bcl-2 inhibitörü olan venetoclax’ın kemoduyarlılaştırma ve sitotoksik etkisinin değerlendirilmesi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '250',
                'program_id' => 50,
                'speaker_id' => 86,
                'code' => 'S-25',
                'title' => ' Gastrointestinal Stromal Tümör Tanılı Hastaların Klinikopatolojik Özellikleri: Tek Merkez Deneyimi ',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '260',
                'program_id' => 50,
                'speaker_id' => 87,
                'code' => 'S-26',
                'title' => 'Gastrointestinal Stromal Tümör Tanısı Alan Hastaların Demografik Değerlendirilmesi ‘Tek Merkez Deneyimi’ ',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '270',
                'program_id' => 50,
                'speaker_id' => 88,
                'code' => 'S-27',
                'title' => 'Metastatik gastrointestinal stromal tümörlerde sağ kalımı etkileyen faktörler: tek merkez deneyimi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '280',
                'program_id' => 50,
                'speaker_id' => 89,
                'code' => 'S-28',
                'title' => 'Metastatik gastrointestinal stromal tümörlerde sağ kalımı etkileyen faktörler: tek merkez deneyimi',
                'start_at' => '2023-11-03 10:30',
                'finish_at' => '2023-11-03 12:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
            [
                'sort_order' => '290',
                'program_id' => 51,
                'speaker_id' => 90,
                'code' => 'S-29',
                'title' => 'İnvaziv Lobüler Meme Kanseri Görüntülemesinde 68Ga-FAPI-PET/BT, 18FDG-PET/BT’ye Alternatif Olabilir mi? ',
                'start_at' => '2023-11-03 13:30',
                'finish_at' => '2023-11-03 15:30',
                'on_air' => 0,
                'questions_limit' => 3,
                'questions_allowed' => 0,
                'questions_auto_start' => 0,
                'is_questions_started' => 0,
                'status' => 1,
            ],
        ]);
    }
}
